Loading stock data…
$6.41-0.01 (-0.16%)
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally.
Lifecore Biomedical, Inc. in the Healthcare sector is trading at $6.41 with a market capitalization of $159M. Wall Street consensus targets $6.28 (1 analysts), implying a -2.0% move over the next 12 months. The stock is currently 29% below its 52-week high of $8.98, remaining 14.5% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $34.17M↑ | $23.19M↓ | $31.11M↓ | $36.44M↑ | $35.15M |
| Gross Profit | $12.07M↑ | $4.46M↓ | $7.79M↓ | $13.98M↑ | $9.85M |
| Operating Income | $2.57M↑ | -$4.67M↓ | -$3.07M↓ | $2.90M↑ | -$2.18M |
| Net Income | -$6.16M↑ | -$14.98M↓ | -$9.99M↓ | -$1.15M↑ | -$14.77M |
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services i...